Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q4 FY23 results · Jan–Mar 2023
Amrutanjan Health Care reported revenue from operations of ₹100.32 crore (down 5.9% from Q4 FY22) and net profit of ₹12.70 crore (down 13.7% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a standalone basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 100.32 | 106.55 | −5.9% | 97.65 | +2.7% |
| Other income | 4.82 | 5.16 | −6.6% | 3.68 | +31.1% |
| Total income | 105.14 | 111.71 | −5.9% | 101.32 | +3.8% |
| Profit before tax | 16.47 | 20.02 | −17.7% | 14.50 | +13.6% |
| Net profit for the period | 12.70 | 14.71 | −13.7% | 10.71 | +18.5% |
| EPS, basic (₹) | 4.35 | 5.09 | −14.5% | 3.67 | +18.5% |
| Net margin (%) | 12.7 | 13.8 | 11.0 |
Standalone
- Filed with BSE
- 31 May 2023, 16:09 IST
- Board meeting
- 30 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE